Kissing Bug Bites: Chagas Disease Research and Prevention
Author: University of Toronto
Published: 2010/04/29 - Updated: 2026/02/06
Publication Type: Research, Study, Analysis
Category Topic: Offbeat News - Related Publications
Page Content: Synopsis - Introduction - Main - Insights, Updates
Synopsis: This research from the University of Toronto addresses Chagas disease, a neglected tropical illness affecting an estimated 15 to 19 million people across Central and South America. The work proves particularly valuable because it takes a novel approach to disease prevention by targeting the insect vector's biological processes rather than relying solely on traditional insecticides or anti-parasitic medications. PhD candidate Jean-Paul Paluzzi's findings about the genetic mechanisms controlling fluid elimination in reduvid bugs (kissing bugs) offer practical hope for developing new prevention methods that could protect vulnerable populations, including elderly individuals and those with mobility limitations who may be particularly susceptible to nighttime insect bites. The research holds significance for people with disabilities because Chagas disease's chronic symptoms - including severe heart disease and intestinal complications - can create additional health burdens that compound existing conditions - Disabled World (DW).
Introduction
Kissing Bug Causes Chagas Disease
It makes your skin crawl, a bug that crawls onto your lips while you sleep, drawn by the exhaled carbon dioxide, numbs your skin, bites, then gorges on your blood. And if that's not insult enough, it promptly defecates on the wound-and passes on a potentially deadly disease.
Now Jean-Paul Paluzzi, a PhD candidate in biology at the University of Toronto Mississauga, believes that manipulating physiology to prevent the insects from leaving their messy calling card represents the best hope for stopping the transmission of the illness, known as Chagas' disease.
"This is a disease of the poor," says Paluzzi, who has visited parts of the world affected by the illness. "The bugs are found in makeshift homes with mud walls and palm tree-like ceilings. Unfortunately, the people of Central and South America that this affects don't have sufficient voice to get help. Given that there are roughly 15 to 19 million people that are infected-a substantial proportion of that area's population-it's a disease that's been neglected."
Main Content
Chagas' disease is one of the major health problems in South and Central America and is spread by reduvid bugs, also known as "kissing bugs" because of their fondness for lips.
The disease they transmit is caused by Trypanosoma cruzi, a parasite that lives in their gut. In the initial acute stage, symptoms are relatively mild, but as the disease progresses over several years, serious chronic symptoms can appear, such as heart disease and malformation of the intestines. Without treatment, it can be fatal. Currently, insecticide sprays are used to control insect populations, and anti-parasitic drugs are somewhat successful at treating acute infections. Once the disease is chronic, it cannot be cured.
To make matters worse, kissing bugs are particularly "bloodthirsty". In mosquitoes, which go through four distinct stages of development, only adult females feed on blood (and potentially transmit disease). This means that pest control methods need to target only one out of eight stages (when you include both sexes). But in kissing bugs, each sex feeds on blood through all fives stages of development. "So you have about a ten-fold greater chance of infection just because of the number of times that these insects have to feed," says Paluzzi.
His research focuses on insect diuresis-more specifically, the genes and peptides that control how the kissing bug eliminates excess fluid in its gut after it gorges on blood. For the insect, the real prize in its meal is the red blood cells, while the water and salt is "excess baggage". After they feed, the bugs are bloated and sluggish, and must jettison the waste so they can make their escape.

How it Happens
When the kissing bug finds a snoozing victim and feeds, its levels of serotonin and diuretic hormones rise sharply, targeting the insect's mid-gut and Malpighian tubules (the equivalent of kidneys), and triggering the release of waste. About four hours later, a peptide named CAP2b is released in the insect's gut, abolishing the effect of the diuretic hormones.
Paluzzi has identified two genes (RhoprCAPA-alpha and RhoprCAPA-beta) that carry the chemical recipe for the peptides that stop diuresis. With that information, he hopes to create a peptide "agonist", something that would enhance the activity of the CAP2B peptide and prevent the insect from leaving waste (and the parasite) on the wound.
In theory, says Paluzzi, this might be an insecticide-like room spray or topical lotion that is biologically stable and has no effect on humans or other insects. Paluzzi is collaborating with a structural biochemist at the U.S. Food and Drug Administration in Texas, with the ultimate goal of creating a pest control solution, but he cautions that a market-ready product is many years away.
The research was funded by the Natural Sciences and Engineering Research Council of Canada, through a discovery grant to Professor Ian Orchard of the Department of Biology and a Canada Graduate Scholarship to Paluzzi.
Insights, Analysis, and Developments
Editorial Note: The fight against Chagas disease represents more than just medical innovation - it's about health equity for marginalized communities. While kissing bugs won't vanish overnight, Paluzzi's research into peptide manipulation offers a glimpse at what targeted biological intervention can achieve. For the millions living in affected regions, many already facing economic hardship and limited healthcare access, a topical prevention method could prove transformative. The timeline may stretch years into the future, but the science is moving forward, and that matters for people whose voices have too often gone unheard in global health conversations - Disabled World (DW).Attribution/Source(s): This quality-reviewed publication was selected for publishing by the editors of Disabled World (DW) due to its relevance to the disability community. Originally authored by University of Toronto and published on 2010/04/29, this content may have been edited for style, clarity, or brevity.